Ipsen S.A. publishes its 2023 Consolidated Financial Statements
Ipsen S.A. – 2023 Consolidated Financial Statements
Attachment
Testing the import & export
Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline
IPSEN – Buy-back programme – Art 5 of MAR – Week 49- 2025
Ipsen – November 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
IPSEN – Buy-back programme – Art 5 of MAR – Week 48 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 47 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 46 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 45 – 2025
Ipsen – October 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
IPSEN – Buy-back programme – Art 5 of MAR – Week 44 – 2025
IPSEN – Buy-back programme – Art 5 of MAR – Week 43 – 2025